KALA BIO, Inc. (KALA) NASDAQ
2.39
+0.19(+8.64%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
2.39
+0.19(+8.64%)
Currency In USD
| Market Cap | 226.52M |
| Enterprise Value | 218.97M |
| P/E Ratio | -0.99 |
| PEG Ratio | -0.01 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 1.81 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -1.78 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -1.6 |
| Return On Equity | -13.36 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -23.39M |
| Net Income | -26.98M |
| Diluted EPS | -3.31 |
| Total Cash | 8.76M |
| Total Cash/Share | 1.08 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 7.91 |
| Book Value Per Share | 1.32 |
| 52-Week Change | -98.64 |
| 52-Week High | 1,030 |
| 52-Week Low | 2.1 |
| Moving Average 50 Days | 6.6 |
| Moving Average 200 Days | 130.08 |
| Average Volume | 171,573 |
| Shares Outstanding | 21.93M |
| % Held by Institutions | 20.86 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:50 |
| Last Split Date | May 11, 2026 |